Oak HC/FT
Oak HC/FT is a venture and growth equity investment firm that focuses on healthcare information services and financial service technology.
Business Model: B2B
Revenue: $5.8M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Oak HC/FT Information
Geographic Data
Address: 3 Pickwick Plz
City: Greenwich
State: CT
Zip: 06830
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$5B
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
3,037,005Website Global Rank
5,707Website Monthly Traffic
Twitter Followers
Description
Oak HC/FT is a venture and growth equity investment firm that focuses on healthcare information services and financial service technology. The firm focuses on driving transformation in these industries by providing entrepreneurs and companies with strategic counsel, board-level participation, and access to our extensive network of industry leaders. Oak HC/FT partners are peerless in delivering returns for investors and growing innovative businesses. Over the past decade, the partners at Oak HC/FT have had 20 realizations with 6 companies achieving valuations in excess of $1 billion. Oak HC/FT is led by the Healthcare and FinTech team of Oak Investment Partners as part of Oak’s strategy to develop sector-specific funds and continue its legacy of building best-in-class businesses.
Contact Phone:
+12037171350
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2021 | Cricket Health | Series B | 0 |
| 6/2021 | AllyAlign Health | Venture Round | - |
| 11/2021 | Aplazo | Series A | 27M |
| 12/2019 | Panorays | Series A | 15M |
| 2/2016 | Maestro Health | Series A | 53M |
| 7/2018 | Therapy Brands | Private Equity Round | - |
| 4/2021 | Clearco | Debt Financing | 248.2M |
| 10/2020 | Rialtic | Series A | 15M |
| 6/2016 | US HealthVest | Series B | 50M |
| 3/2015 | Quartet Health | Series A | 7M |
| 10/2019 | Namogoo | Series C | 40M |
| 10/2015 | Insureon | Series B | 0 |
| 9/2020 | NextCapital | Series D | 30M |
| 11/2021 | EasySend | Series B | 50.5M |
| 6/2022 | CareBridge | Venture Round | 0 |
| 2/2020 | Sendoso | Series B | 40M |
| 9/2019 | Firefly Health | Series A | 10.2M |
| 4/2021 | Firefly Health | Series B | 40M |
| 3/2020 | Olive | Series E | 52M |
| 11/2021 | Justt | Series B | 50M |
| 8/2019 | Wisetack | Series A | 15M |
| 9/2018 | Notable | Series A | 13.5M |
| 11/2021 | Notable | Series B | 100M |
| 9/2022 | MPCH Labs | Series A | 40M |
| 3/2021 | Advise Health | Series A | 100M |
| 2/2021 | Circulo | Series A | 50M |
| 6/2019 | Ocrolus | Series B | 24M |
| 5/2021 | Groups Recover Together | Series C | 60M |
| 11/2021 | U.S. Medical Management | Venture Round | - |
| 10/2016 | Aspire Health | Series D | 32M |
| 6/2020 | DispatchHealth | Series C | 135.8M |
| 7/2021 | VEDA Data Solutions | Series B | 45M |
| 4/2017 | Trōv | Series D | 0 |
| 9/2015 | VillageMD | Series A | 36M |
| 7/2020 | Sema4 | Series C | 121M |
| 2/2022 | Syllable | Series C | 0 |
| 9/2019 | VillageMD | Series B | 100M |
| 5/2019 | Galileo | Series A | - |
| 3/2022 | 99 Minutos | Series C | 0 |
| 12/2019 | Brightline | Seed Round | 5M |
| 9/2020 | Olive | Series F | 106M |
| 10/2015 | Poynt | Series B | 28M |
| 8/2018 | Everside Health | Growth | 165M |
| 4/2021 | Clearco | Series C | 99.1M |
| 5/2020 | CLARA Analytics | Series B | 0 |
| 10/2018 | Devoted Health | Series B | 0 |
| 2/2019 | Kryon | Series C | 40M |
| 9/2021 | TurningPoint Healthcare Solutions | Private Equity Round | - |
| 9/2021 | Panorays | Series B | 0 |
| 3/2023 | Panorays | Series C | - |
| 1/2020 | Vesta Healthcare | Series A | 30M |
| 12/2021 | Reveleer | Venture Round | 0 |
| 8/2018 | Pagaya | Series B | 0 |
| 4/2019 | Pagaya | Series C | 25M |
| 11/2014 | FastPay | Venture Round | 15M |
| 3/2016 | Trōv | Series C | 0 |
| 11/2021 | Infusion for Health | Venture Round | 0 |
| 5/2015 | Feedzai | Series B | 17.5M |
| 8/2019 | Sema4 | Series B | 120M |
| 11/2021 | ZenBusiness | Series C | 200M |
| 6/2021 | Syllable | Series B | 28M |
| 7/2020 | August Bioservices | Venture Round | - |
| 2/2020 | Wayspring | Series C | 15M |
| 5/2020 | OncoHealth | Series C | 28M |
| 10/2016 | Wayspring | Series B | 16.5M |
| 9/2021 | Wayspring | Series D | 0 |
| 6/2020 | Urjanet | Series D | 14.7M |
| 9/2022 | Ethic | Series C | 50M |
| 6/2015 | Aspire Health | Series C | 15M |
| 9/2020 | Truepill | Series C | 75M |
| 3/2019 | Unite Us | Series B | 0 |
| 7/2022 | Everside Health | Venture Round | 0 |
| 11/2018 | OncoHealth | Series B | 21M |
| 3/2022 | Rialtic | Series A | 0 |
| 6/2020 | Pagaya | Series D | 0 |
| 8/2020 | Ocrolus | Series B | 13.5M |
| 3/2017 | Urjanet | Series C | 0 |
| 5/2021 | August Bioservices | Series A | 23.6M |
| 1/2018 | NextCapital | Series C | 0 |
| 7/2015 | Core Informatics | Series B | 17.5M |
| 1/2020 | Komodo Health | Series C | 50M |
| 10/2014 | Limeade | Series C | 25M |
| 9/2018 | Cricket Health | Series A | 0 |
| 12/2021 | Quartet Health | Corporate Round | 60M |
| 5/2021 | Noom | Series F | 540M |
| 10/2020 | Cerebral | Series A | 35M |
| 9/2018 | Maven Clinic | Series B | 27M |
| 11/2022 | Maven Clinic | Series E | 90M |
| 10/2019 | Rapyd | Series C | 100M |
| 1/2021 | Rapyd | Series D | 300M |
| 8/2020 | Brightline | Series A | 0 |
| 11/2022 | DispatchHealth | Series E | 330M |
| 3/2022 | Osso VR | Series C | 0 |
| 7/2018 | Groundspeed Analytics | Series B | 30M |
| 1/2021 | Groundspeed Analytics | Series C | - |
| 10/2016 | LDI | Private Equity Round | - |
| 3/2021 | DispatchHealth | Series D | 0 |
| 4/2022 | IMMO Capital | Series B | 0 |
| 8/2018 | Everside Health | Private Equity Round | 165M |
| 10/2021 | Modern Age | Series A | 0 |
| 7/2022 | Everside Health | Private Equity Round | 164M |
| 12/2022 | August Bioservices | Series B | 0 |
| 7/2022 | Aptos | Series A | 0 |
| 6/2018 | OODA Health | Series A | 0 |
| 9/2021 | Sendoso | Series C | 0 |
| 4/2016 | Quartet Health | Series B | 40M |
| 8/2021 | Cart.com | Series B | 0 |
| 11/2020 | WithMe Health | Series B | 25M |
| 9/2021 | Highnote | Series A | 0 |
| 1/2020 | CareBridge | Venture Round | 40M |
| 6/2021 | Brightline | Series B | 0 |
| 10/2017 | Devoted Health | Series A | 62M |
| 1/2018 | Quartet Health | Series C | 45M |
| 6/2019 | Quartet Health | Series D | 0 |
| 10/2015 | Digital Currency Group | Seed Round | - |
| 4/2021 | Paxos | Series D | 0 |
| 12/2017 | Kasisto | Series B | 17M |
| 9/2019 | Kasisto | Series B | 15M |
| 12/2019 | Inscripta | Series D | 125M |
| 3/2022 | Brightline | Series C | 0 |
| 3/2022 | Mendel.ai | Series B | 40M |
| 3/2021 | Ethic | Series B | 29M |
| 10/2020 | Highnote | Seed Round | 11.5M |
| 1/2016 | CareGuardian | Series B | 27.5M |
| 7/2018 | Olive | Series D | 32.8M |
| 11/2020 | WithMe Health | Series B | 20M |
| 11/2019 | AU10TIX | Venture Round | 20M |
| 11/2018 | Vesta Healthcare | Series A | 10M |
| 6/2021 | Cerebral | Series B | 127M |
| 4/2021 | Vesta Healthcare | Venture Round | 65M |
| 2/2020 | Maven Clinic | Series C | 52M |
| 1/2018 | CLARA Analytics | Series A | 11.5M |
| 9/2021 | Ocrolus | Series C | 80M |
| 8/2021 | Maven Clinic | Series D | 110M |
| 7/2022 | Everside Health | Venture Round | 0 |
| 7/2022 | Aptos | Series A | 0 |
| 6/2022 | CareBridge | Venture Round | 0 |
| 4/2022 | IMMO Capital | Series B | 0 |
| 3/2022 | Brightline | Series C | 0 |
| 3/2022 | Mendel.ai | Series B | 0 |
| 3/2022 | Osso VR | Series C | 0 |
| 3/2022 | Rialtic | Series A | 0 |
| 3/2022 | 99 Minutos | Series C | 0 |
| 2/2022 | Syllable | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
